Covered recipient · General Payments record
CHERYL C MATTERN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2023
$289.20
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $248.11 | 14 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $50.34 | 3 |
| BAXTER HEALTHCARE | $40.14 | 2 |
| DEXCOM, INC. | $32.93 | 1 |
| GlaxoSmithKline, LLC. | $30.17 | 2 |
| Lilly USA, LLC | $29.54 | 2 |
| Merck Sharp & Dohme Corporation | $22.01 | 1 |
| Novo Nordisk AS | $15.69 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.04 | 1 |
| Acerta Pharma LLC | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.25 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016186783 | CMS |
| Baxter Healthcare | $26.80 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998497865 | CMS |
| Baxter Healthcare | $13.34 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998497867 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.04 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996575983 | CMS |
| Dexcom, Inc. | $32.93 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054855563 | CMS |
| GlaxoSmithKline, LLC. | $14.09 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003355387 | CMS |
| GlaxoSmithKline, LLC. | $16.08 | 09/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003353797 | CMS |
| Lilly USA, LLC | $14.65 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031315143 | CMS |
| Lilly USA, LLC | $14.89 | 08/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031317039 | CMS |
| Merck Sharp & Dohme LLC | $22.01 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048924917 | CMS |
| Novo Nordisk Inc | $15.69 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002965393 | CMS |
| PFIZER INC. | $18.21 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050374529 | CMS |
| PFIZER INC. | $16.73 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050622375 | CMS |
| PFIZER INC. | $15.40 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050571029 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.